In 2025, Teva Pharmaceutical Industries Limited.. conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 102,500a | 102,097a | 104,615a | |
Total Waste Recovered | 47,017a | 43,039a | 42,542a | |
Total Hazardous Waste Generated | 63,999a | 61,478a | 61,552a | |
Non-Hazardous Waste Disposed | 16,086a | 16,558a | 20,653a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Teva Pharmaceutical Industries Limited.. generated a total of 102,500metric tonnes of waste.a
Of this amount, 45.87% of Teva Pharmaceutical Industries Limited..'s total waste generated was recovered through methods such as recycling, reuse, or composting, while 54.13% was disposed of through landfilling, incineration, or combustion.a
In 2025, Teva Pharmaceutical Industries Limited.. reported a total waste generation of 102,500 metric tonnes, of which 45.87% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Teva Pharmaceutical Industries Limited.. is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2023, Teva Pharmaceutical Industries Limited..'s total waste generation decreased by 2.02%, and remained stable in 2025, which may indicate a new baseline following earlier reductions in waste output.a
Over the same period, Teva Pharmaceutical Industries Limited..'s waste recovery rate increased by 12.8%, including a 8.81% rise in 2025, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.a
Overall, Teva Pharmaceutical Industries Limited.. appears to have stabilized its waste output following a period of long-term reduction, while continuing to improve its recovery practices. This suggests consolidation of earlier gains with stronger waste treatment efforts.
In 2025, Teva Pharmaceutical Industries Limited.. generated a total of 102,500 metric tonnes of waste.a
Of this amount, 62.44% of Teva Pharmaceutical Industries Limited..'s total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.37.56% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, Teva Pharmaceutical Industries Limited..'s total waste generation decreased by 2.02%, and remained stable in 2025, signaling a plateau following previous reductions that may mark a new waste baseline.a
Over the same period, the share of hazardous waste in Teva Pharmaceutical Industries Limited..'s total output increased by 6.12%, including a further 3.69% rise in 2025, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.a
Overall, Teva Pharmaceutical Industries Limited..'s waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2025, Teva Pharmaceutical Industries Limited.. reported that 63,999 metric tonnes of its total waste output were classified as hazardous. This represents 62.44% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Approximately 38.44% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a